GLIMCIT – M2 SR
Glimepiride 2 mg + Metformin Hydrochloride 500 mg Bilayered Sustained Release Tablet
Glimcit-M2 SR Tablet by Citric Labs is a premium quality anti-diabetic formulation containing Glimepiride 2 mg and Metformin Hydrochloride 500 mg in sustained release bilayered technology. It is designed to support effective blood glucose management in patients with Type 2 Diabetes Mellitus when lifestyle modifications alone are not sufficient.
Composition
- Glimepiride 2 mg
- Metformin Hydrochloride 500 mg (Bilayered Tablet & Sustained Release)
Key Benefits
- Glimepiride 2 mg + Metformin Hydrochloride 500 mg Combination
- Bilayered Sustained Release Tablet Technology
- Effective Diabetes Management Support
- Improved Patient Compliance
- High-Quality Manufacturing Standards
- Suitable for PCD Pharma Franchise & Distribution Opportunities
Product Description
Glimcit-M2 SR Tablet contains Glimepiride 2 mg + Metformin Hydrochloride 500 mg (Bilayered Sustained Release Tablet), a quality anti-diabetic formulation by Citric Labs. Designed for effective blood sugar management in Type 2 Diabetes, it offers advanced sustained release technology for improved patient compliance. Citric Labs provides high-quality diabetes care medicines with excellent PCD Pharma Franchise opportunities across India.
Related products
Why Choose Citric Labs for PCD Pharma Franchise?
- High-quality WHO-GMP certified products
- Monopoly-based PCD Pharma Franchise opportunities
- Strong product portfolio including pain management range
- Competitive pricing & high margins
- Reliable supply chain across India
